5-bromo-2',3'-dideoxyuridine has been researched along with lamivudine in 1 studies
Studies (5-bromo-2',3'-dideoxyuridine) | Trials (5-bromo-2',3'-dideoxyuridine) | Recent Studies (post-2010) (5-bromo-2',3'-dideoxyuridine) | Studies (lamivudine) | Trials (lamivudine) | Recent Studies (post-2010) (lamivudine) |
---|---|---|---|---|---|
8 | 0 | 1 | 7,025 | 1,425 | 2,177 |
Protein | Taxonomy | 5-bromo-2',3'-dideoxyuridine (IC50) | lamivudine (IC50) |
---|---|---|---|
Capsid protein | Hepatitis B virus | 0.1 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Agrawal, B; Johar, M; Kumar, R; Kunimoto, DY; Manning, T; Rai, D; Srivastav, NC | 1 |
1 other study(ies) available for 5-bromo-2',3'-dideoxyuridine and lamivudine
Article | Year |
---|---|
Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
Topics: Adenosine; Alkynes; Animals; Anti-Bacterial Agents; Cell Line; Cell Survival; Dideoxynucleosides; Drug Resistance, Bacterial; Guanosine; Microbial Sensitivity Tests; Mycobacterium avium; Mycobacterium bovis; Mycobacterium tuberculosis; Purine Nucleosides; Structure-Activity Relationship; Uridine | 2007 |